Results 71 to 80 of about 17,769,272 (338)

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

open access: yesNew England Journal of Medicine, 2011
Background The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening.
D. R. Aberle   +9 more
semanticscholar   +1 more source

Fiber Optic Plate Coupled Pb-Free Perovskite X‑ray Camera Featuring Low-Dose-Rate Imaging toward Dental Diagnosis

open access: yes, 2023
Copper-based halide perovskites have been considered as promising scintillators. However, they still cannot meet the requirement of low-dose-rate X-ray imaging in medical diagnosis.
Jizhong Song (1722274)   +15 more
core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Comparative analysis of LDR and HDR intracavitary brachytherapy in cervical cancer: the critical role of overall treatment time — a decade of experience

open access: yesReports of Practical Oncology and Radiotherapy
BACKGROUND: This study compares low dose rate (LDR) and high dose rate (HDR) intracavitary brachytherapy (ICBT) in the treatment of cervical cancer treated at a tertiary care cancer centre in North India.
Purnima Thakur   +5 more
doaj   +1 more source

The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation

open access: yesInternational Journal of Radiation Biology, 2016
Purpose: This review evaluates the role of dose rate on cell and molecular responses. It focuses on the influence of dose rate on key events in critical pathways in the development of cancer. This approach is similar to that used by the U.S.
Antone L. Brooks, D. Hoel, R. Preston
semanticscholar   +1 more source

A new mathematical model for radiation cell killing mechanism: Target cumulating model [PDF]

open access: yes, 2009
There are numerous mathematical or statistical models have been given out for radiation cell killing mechanism. Unfortunately, none of the model could explain the mechanism perfectly.
Xie Congyin   +3 more
core  

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad   +9 more
wiley   +1 more source

Continuous Low-Dose-Rate Irradiation Promotes Growth of Silkworms

open access: yesDose-Response, 2017
To investigate the influence of low-dose-rate irradiation on the growth of silkworms, Bombyx mori , eggs of silkworms were randomly divided into 2 groups and were grown on either low-dose-radiation-emitting sheets or control sheets.
Yuta Shibamoto   +4 more
doaj   +1 more source

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center

open access: yes, 2021
Purpose: Until now, most long-term results for brachytherapy only has been published for low-dose-rate (LDR) seeds. Due to radiobiology reasons, high-dose-rate (HDR) mono-brachytherapy is of growing interest.
Bengt Johansson   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy